Despite this background understanding, if, how and to what extent SSH1 is involved tumor initiation, cancer metastasis, resistance to therapy, and poor prognosis remain largely under-explored, and more so compounded by our limited understanding of how the seemingly opposing actions of SSH1 are controlled in the context of the HCC microenvironment. This evidence concerns the gene SSH1 and neoplasm.